Patterns of Care and Outcomes of Primary Adenoid Cystic Carcinoma of the Trachea

医学 腺样囊性癌 癌症 队列 比例危险模型 恶性肿瘤 回顾性队列研究 外科 生存分析 内科学
作者
Sara Behbahani,Gregory L. Barinsky,David W. Wassef,Boris Paskhover,Rachel Kaye
出处
期刊:Annals of Otology, Rhinology, and Laryngology [SAGE Publishing]
卷期号:131 (1): 78-85 被引量:2
标识
DOI:10.1177/00034894211008101
摘要

Primary tracheal malignancies are relatively rare cancers, representing 0.1% to 0.4% of all malignancies. Adenoid cystic carcinoma (ACC) is the second most common histology of primary tracheal malignancy, after squamous cell carcinoma. This study aims to analyze demographic characteristics and potential influencing factors on survival of tracheal ACC (TACC).This was a retrospective cohort study utilizing the National Cancer Database (NCDB). The NCDB was queried for all cases of TACC diagnosed from 2004 to 2016 (n = 394). Kaplan-Meier (KM) and Cox proportional-hazards models were used to determine clinicopathological and treatment factors associated with survival outcomes.Median age of diagnosis was 56 (IQR: 44.75-66.00). Females were affected slightly more than males (53.8% vs 46.2%). The most prevalent tumor diameter range was 20 to 39 mm (34.8%) followed by greater than 40 mm in diameter (17.8%). Median overall survival (OS) was 9.72 years with a 5- and 10-year OS of 70% and 47.5%, respectively. Localized disease was not associated with a survival benefit over invasive disease (P = .388). The most common intervention was surgery combined with radiation therapy (RT) at 46.2%, followed by surgery alone (16.8%), and standalone RT (8.9%). When adjusting for confounders, surgical resection was independently associated with improved OS (HR 0.461, 95% CI 0.225-0.946). Tumor size greater than 40 mm was independently associated with worse OS (HR 2.808; 95% CI 1.096-7.194).Our data suggests that surgical resection, possibly in conjunction with radiation therapy, is associated with improved survival, and tumor larger than 40 mm are associated with worse survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lucas应助LLLLLLLL采纳,获得10
刚刚
王志鹏完成签到 ,获得积分10
1秒前
huangwenyu完成签到,获得积分10
2秒前
多情的捕完成签到,获得积分10
3秒前
Ares完成签到,获得积分10
4秒前
5秒前
xiying完成签到 ,获得积分10
6秒前
开朗的绮山完成签到,获得积分10
7秒前
qwe完成签到,获得积分10
7秒前
小权拳的权完成签到,获得积分10
8秒前
EVER完成签到 ,获得积分10
8秒前
502s完成签到,获得积分10
10秒前
13秒前
桃子完成签到 ,获得积分10
13秒前
昆昆完成签到,获得积分10
13秒前
欣欣子完成签到 ,获得积分10
13秒前
在路上完成签到,获得积分0
15秒前
LLLLLLLL发布了新的文献求助10
16秒前
eternal_dreams完成签到 ,获得积分10
17秒前
18秒前
Ling完成签到,获得积分10
21秒前
王十二完成签到 ,获得积分10
21秒前
dypdyp应助Wang采纳,获得10
21秒前
研友_8RlQ2n完成签到,获得积分10
22秒前
Zhangll完成签到,获得积分10
23秒前
肖耶啵完成签到,获得积分10
24秒前
好困发布了新的文献求助10
24秒前
Ranrunn完成签到,获得积分10
24秒前
LLLLLLLL完成签到,获得积分10
26秒前
DrLuffy完成签到 ,获得积分10
26秒前
奈何桥完成签到,获得积分10
27秒前
无语的断缘完成签到,获得积分10
31秒前
amwlsai完成签到,获得积分10
33秒前
闪闪青雪完成签到,获得积分10
33秒前
踏实大侠完成签到,获得积分10
33秒前
舒心老五发布了新的文献求助10
34秒前
小詹完成签到,获得积分10
34秒前
double完成签到,获得积分20
34秒前
34秒前
KUZZZ完成签到,获得积分10
34秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968578
求助须知:如何正确求助?哪些是违规求助? 3513406
关于积分的说明 11167631
捐赠科研通 3248853
什么是DOI,文献DOI怎么找? 1794499
邀请新用户注册赠送积分活动 875150
科研通“疑难数据库(出版商)”最低求助积分说明 804671